Linked Data API

Show Search Form

Search Results

1132763
star this property registered interest false more like this
star this property date less than 2019-06-18more like thismore than 2019-06-18
star this property answering body
Department of Health and Social Care more like this
star this property answering dept id 17 more like this
star this property answering dept short name Health and Social Care more like this
star this property answering dept sort name Health and Social Care remove filter
star this property hansard heading Patients: Safety more like this
star this property house id 1 more like this
star this property legislature
25259
star this property pref label House of Commons more like this
star this property question text What steps he is taking to ensure NHS patient safety. more like this
star this property tabling member constituency Stafford more like this
star this property tabling member printed
Jeremy Lefroy more like this
star this property uin 911420 more like this
star this property answer
answer
star this property is ministerial correction false more like this
star this property date of answer less than 2019-06-18more like thismore than 2019-06-18
unstar this property answer text <p>Patient safety remains a key priority for the National Health Service. NHS Improvement and NHS England are developing a new National Patient Safety Strategy that will sit alongside the NHS Long Term Plan.</p><p>The strategy will be published this summer and will build on existing work to provide a coherent framework that the whole NHS can recognise and support</p> more like this
star this property answering member constituency Gosport remove filter
star this property answering member printed Caroline Dinenage more like this
star this property question first answered
less than 2019-06-18T15:03:47.607Zmore like thismore than 2019-06-18T15:03:47.607Z
unstar this property answering member
4008
star this property label Biography information for Caroline Dinenage more like this
star this property tabling member
4109
unstar this property label Biography information for Jeremy Lefroy more like this
1132766
star this property registered interest false more like this
star this property date less than 2019-06-18more like thismore than 2019-06-18
star this property answering body
Department of Health and Social Care more like this
star this property answering dept id 17 more like this
star this property answering dept short name Health and Social Care more like this
star this property answering dept sort name Health and Social Care remove filter
star this property hansard heading Social Services more like this
star this property house id 1 more like this
star this property legislature
25259
star this property pref label House of Commons more like this
star this property question text What steps he is taking to improve social care. more like this
star this property tabling member constituency Thirsk and Malton more like this
star this property tabling member printed
Kevin Hollinrake more like this
star this property uin 911424 more like this
star this property answer
answer
star this property is ministerial correction false more like this
star this property date of answer less than 2019-06-18more like thismore than 2019-06-18
unstar this property answer text <p>Local authorities have a duty to ensure people receive appropriate care and support. We have given them access to up to £3.9 billion more dedicated funding for adult social care this year, and a further £410 million has been made available for adult and children’s services.</p><p>We will set out our plans to reform the social care system at the earliest opportunity to ensure it is sustainable for the future.</p> more like this
star this property answering member constituency Gosport remove filter
star this property answering member printed Caroline Dinenage more like this
star this property question first answered
less than 2019-06-18T15:02:18.803Zmore like thismore than 2019-06-18T15:02:18.803Z
unstar this property answering member
4008
star this property label Biography information for Caroline Dinenage more like this
star this property tabling member
4474
unstar this property label Biography information for Kevin Hollinrake more like this
1132427
star this property registered interest false more like this
star this property date less than 2019-06-17more like thismore than 2019-06-17
star this property answering body
Department of Health and Social Care more like this
star this property answering dept id 17 more like this
star this property answering dept short name Health and Social Care more like this
star this property answering dept sort name Health and Social Care remove filter
star this property hansard heading Genetics: Screening more like this
star this property house id 1 more like this
star this property legislature
25259
star this property pref label House of Commons more like this
star this property question text To ask the Secretary of State for Health and Social Care, how many patients have received whole genome sequencing through the NHS; and how many of those patients had a type of blood cancer. more like this
star this property tabling member constituency Totnes more like this
star this property tabling member printed
Dr Sarah Wollaston more like this
star this property uin 265508 more like this
star this property answer
answer
star this property is ministerial correction false more like this
star this property date of answer less than 2019-06-20more like thismore than 2019-06-20
unstar this property answer text <p>As part of the NHS Long Term Plan, the National Health Service has committed to sequencing 500,000 whole genomes by 2023/24.</p><p>During 2019, the NHS will begin to offer whole genome sequencing (WGS) as part of clinical care for:</p><p>- Seriously ill children likely to have a rare genetic disorder;</p><p>- People with one of 21 rare conditions where current evidence supports early adoption of WGS as a diagnostic test; and</p><p>- People with specific types of cancer for which there is likely to be the greatest patient benefit from using WGS – children with cancer, sarcoma and Acute Myeloid Leukaemia.</p><p> </p><p>As the price of whole genome sequencing falls and the evidence improves, we envisage that it will be extended to more conditions and therefore more patients.</p> more like this
star this property answering member constituency Gosport remove filter
star this property answering member printed Caroline Dinenage more like this
star this property grouped question UIN
265509 more like this
265510 more like this
star this property question first answered
less than 2019-06-20T15:34:08.563Zmore like thismore than 2019-06-20T15:34:08.563Z
unstar this property answering member
4008
star this property label Biography information for Caroline Dinenage more like this
star this property tabling member
4073
unstar this property label Biography information for Dr Sarah Wollaston more like this
1132428
star this property registered interest false more like this
star this property date less than 2019-06-17more like thismore than 2019-06-17
star this property answering body
Department of Health and Social Care more like this
star this property answering dept id 17 more like this
star this property answering dept short name Health and Social Care more like this
star this property answering dept sort name Health and Social Care remove filter
star this property hansard heading Genetics: Screening more like this
star this property house id 1 more like this
star this property legislature
25259
star this property pref label House of Commons more like this
star this property question text To ask the Secretary of State for Health and Social Care, how many patients he estimates will benefit from whole genome sequencing in (a) 2019 and (b) each of the next five years. more like this
star this property tabling member constituency Totnes more like this
star this property tabling member printed
Dr Sarah Wollaston more like this
star this property uin 265509 more like this
star this property answer
answer
star this property is ministerial correction false more like this
star this property date of answer less than 2019-06-20more like thismore than 2019-06-20
unstar this property answer text <p>As part of the NHS Long Term Plan, the National Health Service has committed to sequencing 500,000 whole genomes by 2023/24.</p><p>During 2019, the NHS will begin to offer whole genome sequencing (WGS) as part of clinical care for:</p><p>- Seriously ill children likely to have a rare genetic disorder;</p><p>- People with one of 21 rare conditions where current evidence supports early adoption of WGS as a diagnostic test; and</p><p>- People with specific types of cancer for which there is likely to be the greatest patient benefit from using WGS – children with cancer, sarcoma and Acute Myeloid Leukaemia.</p><p> </p><p>As the price of whole genome sequencing falls and the evidence improves, we envisage that it will be extended to more conditions and therefore more patients.</p> more like this
star this property answering member constituency Gosport remove filter
star this property answering member printed Caroline Dinenage more like this
star this property grouped question UIN
265508 more like this
265510 more like this
star this property question first answered
less than 2019-06-20T15:34:08.64Zmore like thismore than 2019-06-20T15:34:08.64Z
unstar this property answering member
4008
star this property label Biography information for Caroline Dinenage more like this
star this property tabling member
4073
unstar this property label Biography information for Dr Sarah Wollaston more like this
1132429
star this property registered interest false more like this
star this property date less than 2019-06-17more like thismore than 2019-06-17
star this property answering body
Department of Health and Social Care more like this
star this property answering dept id 17 more like this
star this property answering dept short name Health and Social Care more like this
star this property answering dept sort name Health and Social Care remove filter
star this property hansard heading Genetics: Screening more like this
star this property house id 1 more like this
star this property legislature
25259
star this property pref label House of Commons more like this
star this property question text To ask the Secretary of State for Health and Social Care, when the NHS Genomic Medicine Service will begin performing whole genome sequencing. more like this
star this property tabling member constituency Totnes more like this
star this property tabling member printed
Dr Sarah Wollaston more like this
star this property uin 265510 more like this
star this property answer
answer
star this property is ministerial correction false more like this
star this property date of answer less than 2019-06-20more like thismore than 2019-06-20
unstar this property answer text <p>As part of the NHS Long Term Plan, the National Health Service has committed to sequencing 500,000 whole genomes by 2023/24.</p><p>During 2019, the NHS will begin to offer whole genome sequencing (WGS) as part of clinical care for:</p><p>- Seriously ill children likely to have a rare genetic disorder;</p><p>- People with one of 21 rare conditions where current evidence supports early adoption of WGS as a diagnostic test; and</p><p>- People with specific types of cancer for which there is likely to be the greatest patient benefit from using WGS – children with cancer, sarcoma and Acute Myeloid Leukaemia.</p><p> </p><p>As the price of whole genome sequencing falls and the evidence improves, we envisage that it will be extended to more conditions and therefore more patients.</p> more like this
star this property answering member constituency Gosport remove filter
star this property answering member printed Caroline Dinenage more like this
star this property grouped question UIN
265508 more like this
265509 more like this
star this property question first answered
less than 2019-06-20T15:34:08.717Zmore like thismore than 2019-06-20T15:34:08.717Z
unstar this property answering member
4008
star this property label Biography information for Caroline Dinenage more like this
star this property tabling member
4073
unstar this property label Biography information for Dr Sarah Wollaston more like this
1132453
star this property registered interest false more like this
star this property date less than 2019-06-17more like thismore than 2019-06-17
star this property answering body
Department of Health and Social Care more like this
star this property answering dept id 17 more like this
star this property answering dept short name Health and Social Care more like this
star this property answering dept sort name Health and Social Care remove filter
star this property hansard heading Arthritis: Health Services more like this
star this property house id 1 more like this
star this property legislature
25259
star this property pref label House of Commons more like this
star this property question text To ask the Secretary of State for Health and Social Care, what steps his Department has taken to (a) ensure patient safety and (b) support pioneering medical research to tackle (i) rheumatoid arthritis and (ii) other inflammatory conditions in the event that the UK leaves the EU without a deal. more like this
star this property tabling member constituency Linlithgow and East Falkirk more like this
star this property tabling member printed
Martyn Day more like this
star this property uin 265579 more like this
star this property answer
answer
star this property is ministerial correction false more like this
star this property date of answer less than 2019-06-20more like thismore than 2019-06-20
unstar this property answer text <p>The Government remains committed to leaving the European Union with a deal. However, as a responsible Government, we must plan for every eventuality, including no deal.</p><p>We have been working closely with partners across the health and care system and industry to ensure the continued health and safety of patients, including ensuring supplies of medicines and medical products, and securing the future of our EU health and care workforce.</p><p>The Department has published EU Exit operational readiness guidance for the health and care system in England outlining actions that providers and commissioners of health and social care services should take to prepare for, and manage, the risks of a no deal exit scenario.</p><p>We continue to monitor and analyse overall staffing levels across the National Health Service and adult social care, and we are working across Government to ensure there will continue to be sufficient staff to deliver the high-quality services on which the public relies following the UK’s exit from the EU.</p><p>The UK has an outstanding track record for research into rheumatoid arthritis and other inflammatory conditions. The Government invests over £1 billion in health research through the National Institute for Health Research (NIHR). This provides direct funding for health research and clinical trials and also the skills, facilities and infrastructure to undertake clinical trials in the health and care service funded by public, charity and industry funders.</p><p>In 2017/18, the NIHR provided £11.7 million funding for research on the inflammatory and immune system (this includes rheumatoid arthritis, connective tissue diseases, autoimmune diseases, allergies and normal development and function of the immune system, as per the UK Clinical Research Collaboration Health Research Classification System, of which £1.2 million was for research on rheumatoid arthritis. In addition, the NIHR Clinical Research Network provides the support to deliver research by public, charity and industry funders in the health and care system.</p><p>The UK and the EU have a long record of jointly tackling global challenges, with strong existing links already in place between our research and innovation communities, and we want to continue this important collaboration in science, research and innovation, including in pioneering medical research for rheumatoid arthritis and other inflammatory conditions.</p><p>As a responsible Government, we are continuing to prepare for all scenarios. In the event that the UK leaves the EU without a deal at the end of this extension period, the Government has confirmed that the funding commitments made under the guarantee and the extension still stand. Through these commitments, the Government will underwrite funding for all successful competitive eligible UK bids to Horizon 2020 that are submitted before the end of the Programme. This guarantee will apply for the lifetime of projects and will provide funding for UK participation in pioneering Horizon 2020 medical research projects can continue.</p><p> </p>
star this property answering member constituency Gosport remove filter
star this property answering member printed Caroline Dinenage more like this
star this property question first answered
less than 2019-06-20T15:36:21.927Zmore like thismore than 2019-06-20T15:36:21.927Z
unstar this property answering member
4008
star this property label Biography information for Caroline Dinenage more like this
star this property tabling member
4488
unstar this property label Biography information for Martyn Day more like this
1132500
star this property registered interest false more like this
star this property date less than 2019-06-17more like thismore than 2019-06-17
star this property answering body
Department of Health and Social Care more like this
star this property answering dept id 17 more like this
star this property answering dept short name Health and Social Care more like this
star this property answering dept sort name Health and Social Care remove filter
star this property hansard heading Disability more like this
star this property house id 1 more like this
star this property legislature
25259
star this property pref label House of Commons more like this
star this property question text To ask the Secretary of State for Health and Social Care, what impact assessment his Department has conducted of the effect on people with disabilities of the UK leaving the EU without a deal. more like this
star this property tabling member constituency Cardiff Central more like this
star this property tabling member printed
Jo Stevens more like this
star this property uin 265545 more like this
star this property answer
answer
star this property is ministerial correction false more like this
star this property date of answer less than 2019-06-20more like thismore than 2019-06-20
unstar this property answer text <p>No formal impact assessment has been conducted by the Department of the effect on people with disabilities of the United Kingdom leaving the European Union without a deal.</p> more like this
star this property answering member constituency Gosport remove filter
star this property answering member printed Caroline Dinenage more like this
star this property question first answered
less than 2019-06-20T09:26:59.077Zmore like thismore than 2019-06-20T09:26:59.077Z
unstar this property answering member
4008
star this property label Biography information for Caroline Dinenage more like this
star this property tabling member
4425
unstar this property label Biography information for Jo Stevens more like this
1132563
star this property registered interest false more like this
star this property date less than 2019-06-17more like thismore than 2019-06-17
star this property answering body
Department of Health and Social Care more like this
star this property answering dept id 17 more like this
star this property answering dept short name Health and Social Care more like this
star this property answering dept sort name Health and Social Care remove filter
star this property hansard heading Medicine: Research more like this
star this property house id 1 more like this
star this property legislature
25259
star this property pref label House of Commons more like this
star this property question text To ask the Secretary of State for Health and Social Care, what assessment of the effect on the UK's future participation in future EU Research Programmes in (a) medical research and (b) drugs of the UK leaving the EU without a deal. more like this
star this property tabling member constituency Mid Sussex more like this
star this property tabling member printed
Sir Nicholas Soames more like this
star this property uin 265405 more like this
star this property answer
answer
star this property is ministerial correction false more like this
star this property date of answer less than 2019-06-20more like thismore than 2019-06-20
unstar this property answer text <p>Leaving the European Union with a deal remains the Government’s priority. However, as a responsible Government, we must plan for every eventuality, including ‘no deal’.</p><p>The United Kingdom and the EU have a long record of jointly tackling global challenges, with strong existing links already in place between our research and innovation communities, and we want to continue this important collaboration in science, research and innovation, including in medical research.</p><p>The Government is committed to continuing to back UK researchers and innovators by supporting measures to enable world-class collaborative research, including support for small businesses. The Department for Business, Energy and Industrial Strategy is working with the National Academies, the devolved administrations and UK Research and Innovation to develop ambitious and credible alternatives to association, through which we will enable world class collaborative research.</p><p>In addition, earlier in the year, the Minister of State for Universities, Science, Research and Innovation (Chris Skidmore MP) commissioned Sir Adrian Smith to provide independent advice on international collaboration – specifically on potential future UK funding schemes in the context of the UK’s future ambitions for European and international collaboration on research and innovation. His advice will help set the direction for the implementation of the Government’s ambition to ensure the UK continues to be a global leader in science, research and innovation, and an attractive country for individuals to study and work.</p><p><strong> </strong></p>
star this property answering member constituency Gosport remove filter
star this property answering member printed Caroline Dinenage more like this
star this property question first answered
less than 2019-06-20T15:30:04.907Zmore like thismore than 2019-06-20T15:30:04.907Z
unstar this property answering member
4008
star this property label Biography information for Caroline Dinenage more like this
star this property tabling member
116
unstar this property label Biography information for Sir Nicholas Soames more like this
1132564
star this property registered interest false more like this
star this property date less than 2019-06-17more like thismore than 2019-06-17
star this property answering body
Department of Health and Social Care more like this
star this property answering dept id 17 more like this
star this property answering dept short name Health and Social Care more like this
star this property answering dept sort name Health and Social Care remove filter
star this property hansard heading Clinical Trials: Finance more like this
star this property house id 1 more like this
star this property legislature
25259
star this property pref label House of Commons more like this
star this property question text To ask the Secretary of State for Health and Social Care, what effect the UK leaving the EU without a deal will have on funding of clinical drug trials; if he will make a statement. more like this
star this property tabling member constituency Mid Sussex more like this
star this property tabling member printed
Sir Nicholas Soames more like this
star this property uin 265406 more like this
star this property answer
answer
star this property is ministerial correction false more like this
star this property date of answer less than 2019-06-20more like thismore than 2019-06-20
unstar this property answer text <p>The United Kingdom and the European Union have a long record of jointly tackling global challenges, with strong existing links already in place between our research and innovation communities, and we want to continue this important collaboration in science, research and innovation.</p><p>The UK and the EU have agreed a flexible extension of the Article 50 period to 31 October 2019. During this extension period the UK will remain a member of the EU, with all the relevant rights and obligations. This means that the UK will continue to participate in Horizon 2020, the EU’s flagship research and innovation programme, on a Member State basis. Further, this extension period provides time for the Government to seek a deal which will ensure the smooth and orderly withdrawal from the EU. If ratified, the proposed Withdrawal Agreement would ensure that following exit the UK could continue to participate in EU programmes such as Horizon 2020 for the lifetime of projects. Further updates on Horizon 2020 planning will be provided in due course.</p><p>As a responsible Government, we are continuing to prepare for all scenarios. In the event that the UK leaves the EU without a deal at the end of this extension period, the Government has confirmed that the funding commitments made under the guarantee and the extension still stand. Through these commitments, the Government will underwrite funding for all successful competitive eligible UK bids to Horizon 2020 that are submitted before the end of the Programme. This guarantee will apply for the lifetime of projects and will provide funding for UK participation in pioneering Horizon 2020 medical research projects can continue.</p><p>Aside from our preparations for leaving the EU, the Government has demonstrated its commitment to research and innovation, including clinical drug trials, by putting it at the heart of its Industrial Strategy, setting an ambition to increase UK total research and development expenditure to 2.4% of gross domestic product by 2027. As a first step towards that we have invested an extra £7 billion in research and development up to 2021/2022. The Government invests over £1 billion in health research through the National Institute for Health Research. This provides direct funding for clinical trials and also the skills, facilities and infrastructure to undertake clinical trials in the health and care service funded by public, charity and industry funders.</p><p> </p><p><strong> </strong></p>
star this property answering member constituency Gosport remove filter
star this property answering member printed Caroline Dinenage more like this
star this property question first answered
less than 2019-06-20T15:31:03.907Zmore like thismore than 2019-06-20T15:31:03.907Z
unstar this property answering member
4008
star this property label Biography information for Caroline Dinenage more like this
star this property tabling member
116
unstar this property label Biography information for Sir Nicholas Soames more like this
1132282
star this property registered interest false more like this
star this property date less than 2019-06-14more like thismore than 2019-06-14
star this property answering body
Department of Health and Social Care more like this
star this property answering dept id 17 more like this
star this property answering dept short name Health and Social Care more like this
star this property answering dept sort name Health and Social Care remove filter
star this property hansard heading Genetics: Screening more like this
star this property house id 1 more like this
star this property legislature
25259
star this property pref label House of Commons more like this
star this property question text To ask the Secretary of State for Health and Social Care, what estimate he has made of the number of patients that will benefit from whole genome sequencing in the first year of its introduction; and what steps is he taking to ensure the adequacy of trained professionals to provide that service. more like this
star this property tabling member constituency Sheffield South East more like this
star this property tabling member printed
Mr Clive Betts more like this
star this property uin 264725 more like this
star this property answer
answer
star this property is ministerial correction false more like this
star this property date of answer less than 2019-06-19more like thismore than 2019-06-19
unstar this property answer text <p>As part of the NHS Long Term Plan, the National Health Service has committed to sequencing 500,000 whole genomes by 2023/24.</p><p>During 2019, the NHS will begin to offer whole genome sequencing (WGS) as part of clinical care for:</p><p>- Seriously ill children likely to have a rare genetic disorder;</p><p>- People with one of 21 rare conditions where current evidence supports early adoption of WGS as a diagnostic test;</p><p>- People with specific types of cancer for which there is likely to be the greatest patient benefit from using WGS – children with cancer, sarcoma and Acute Myeloid Leukaemia.</p><p> </p><p>As the price of whole genome sequencing falls and the evidence improves, we envisage that it will be extended to more conditions and therefore more patients.</p> more like this
star this property answering member constituency Gosport remove filter
star this property answering member printed Caroline Dinenage more like this
star this property question first answered
less than 2019-06-19T16:17:13.117Zmore like thismore than 2019-06-19T16:17:13.117Z
unstar this property answering member
4008
star this property label Biography information for Caroline Dinenage more like this
star this property tabling member
394
unstar this property label Biography information for Mr Clive Betts more like this